| Dr Sabrina D Greer, AUD | |
|
4439 State Route 159 Ste G70, Chillicothe, OH 45601-7203 | |
| (740) 779-4327 | |
| (740) 779-4399 |
| Full Name | Dr Sabrina D Greer |
|---|---|
| Gender | Female |
| Speciality | Audiologist |
| Location | 4439 State Route 159 Ste G70, Chillicothe, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447426846 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | A-01555 (Ohio) | Primary |
| Provider Name | Adena Medical Group Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1235468083 PECOS PAC ID: 1153456579 Enrollment ID: O20100323001007 |
News Archive
The Perrigo Company today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market over-the-counter coated nicotine polacrilex gum USP, 2 mg and 4 mg cinnamon flavor.
U.S. Environmental Protection Agency has awarded grants for research projects totaling almost $1 million to the University of Cincinnati, Ohio State University and the Solid Waste Authority of Central Ohio.
The ultimate goal in cancer research, a treatment that kills cancer cells whilst leaving healthy cells untouched, is brought nearer by the success of a new therapeutic approach. The potential therapy, published in BioMed Central's open access journal Breast Cancer Research, targets proliferation of cancer, but not normal, cells.
Data revealed the mean total PMAS was 64 percent of optimal, suggesting a generally poor score. In fact, they found that less than half of residents with predictably recurrent pain were being prescribed scheduled pain medication; 23 percent received at least one high-risk medication.
› Verified 9 days ago
| Provider Name | Mre Goc Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1699249474 PECOS PAC ID: 6002155868 Enrollment ID: O20190222001614 |
News Archive
The Perrigo Company today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market over-the-counter coated nicotine polacrilex gum USP, 2 mg and 4 mg cinnamon flavor.
U.S. Environmental Protection Agency has awarded grants for research projects totaling almost $1 million to the University of Cincinnati, Ohio State University and the Solid Waste Authority of Central Ohio.
The ultimate goal in cancer research, a treatment that kills cancer cells whilst leaving healthy cells untouched, is brought nearer by the success of a new therapeutic approach. The potential therapy, published in BioMed Central's open access journal Breast Cancer Research, targets proliferation of cancer, but not normal, cells.
Data revealed the mean total PMAS was 64 percent of optimal, suggesting a generally poor score. In fact, they found that less than half of residents with predictably recurrent pain were being prescribed scheduled pain medication; 23 percent received at least one high-risk medication.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sabrina D Greer, AUD 4439 State Route 159 Ste G70, Chillicothe, OH 45601-7203 Ph: (740) 779-4327 | Dr Sabrina D Greer, AUD 4439 State Route 159 Ste G70, Chillicothe, OH 45601-7203 Ph: (740) 779-4327 |
News Archive
The Perrigo Company today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market over-the-counter coated nicotine polacrilex gum USP, 2 mg and 4 mg cinnamon flavor.
U.S. Environmental Protection Agency has awarded grants for research projects totaling almost $1 million to the University of Cincinnati, Ohio State University and the Solid Waste Authority of Central Ohio.
The ultimate goal in cancer research, a treatment that kills cancer cells whilst leaving healthy cells untouched, is brought nearer by the success of a new therapeutic approach. The potential therapy, published in BioMed Central's open access journal Breast Cancer Research, targets proliferation of cancer, but not normal, cells.
Data revealed the mean total PMAS was 64 percent of optimal, suggesting a generally poor score. In fact, they found that less than half of residents with predictably recurrent pain were being prescribed scheduled pain medication; 23 percent received at least one high-risk medication.
› Verified 9 days ago
Dr. Shawn Stewart Cowell, AU.D, CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 17273 State Route 104, Audiology Department (126), Chillicothe, OH 45601 Phone: 740-773-1141 | |
Rachel Brooke Maynard, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 272 Hospital Rd, Chillicothe, OH 45601 Phone: 740-779-7660 | |
Ms. Debra L. Morgan, M.A., CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 4439 State Route 159 Ste G70, Chillicothe, OH 45601 Phone: 740-779-4327 Fax: 740-779-4399 | |
Chelci Jo Gay, DR. Audiologist Medicare: Medicare Enrolled Practice Location: 2530 Western Ave Ste C, Chillicothe, OH 45601 Phone: 740-851-4727 | |
Dr. Erica Lynn Scudder, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 138 Marietta Rd, Chillicothe, OH 45601 Phone: 740-775-4327 | |
Ashtyn Rife, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 4439 State Route 159 Ste G70, Chillicothe, OH 45601 Phone: 740-779-4327 |